{"context":{"query":">>mesh>>pharmgkb_clinical","source_dataset":"mesh","target_dataset":"pharmgkb_clinical"},"stats":{"queried":1,"total":34,"mapped":1},"pagination":{"has_next":false},"schema":"id|variant|gene|type|level_of_evidence|chemicals|phenotypes","mappings":[{"input":"D020521","source":"D020521|Stroke","targets":["CYP2C19*1__CYP2C19*2__CYP2C19*3__CYP2C19*4__CYP2C19*5__CYP2C19*6__CYP2C19*8__CYP2C19*17_CYP2C19_1|CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*5, CYP2C19*6, CYP2C19*8, CYP2C19*17|CYP2C19|Efficacy,Toxicity|1A|clopidogrel|Acute coronary syndrome;Cardiovascular Disease;Stroke;Transient Ischemic Attack","RS1042640_UGT1A_2|rs1042640|UGT1A|Toxicity|3|acetaminophen|Liver Failure;Acute","RS1042919_RRM1_1|rs1042919|RRM1|Efficacy|3|cladribine;cytarabine|Leukemia;Myeloid;Acute","RS1045642_ABCB1_68|rs1045642|ABCB1|Efficacy|3|cytarabine|Leukemia;Myeloid;Acute","RS10929303_UGT1A_2|rs10929303|UGT1A|Toxicity|3|acetaminophen|Liver Failure;Acute","RS11231825_SLC22A12_1|rs11231825|SLC22A12|Toxicity|3|cytarabine;fludarabine;gemtuzumab ozogamicin;idarubicin|Leukemia;Myeloid;Acute","RS1128503_ABCB1_6|rs1128503|ABCB1|Efficacy|3|cytarabine|Leukemia;Myeloid;Acute","RS1130609_RRM2_1|rs1130609|RRM2|Efficacy|3|cladribine;cytarabine|Leukemia;Myeloid;Acute","RS1265138_RRM2B_1|rs1265138|RRM2B|Efficacy|3|cladribine;cytarabine|Leukemia;Myeloid;Acute","RS13058338_RAC2_2|rs13058338|RAC2|Efficacy|3|idarubicin|Leukemia;Myeloid;Acute","RS1561876_RRM1_1|rs1561876|RRM1|Efficacy|3|cladribine;cytarabine|Leukemia;Myeloid;Acute","RS1799963_F2_1|rs1799963|F2|Toxicity|2B|hormonal contraceptives for systemic use|Stroke;Venous Thrombosis","RS1799983_NOS3_2|rs1799983|NOS3|Efficacy|3|daunorubicin|Leukemia;Myeloid;Acute","RS1801020_F12_1|rs1801020|F12|Efficacy|3|Enzymes|Stroke","RS1883112_NCF4_2|rs1883112|NCF4|Efficacy|3|idarubicin|Leukemia;Myeloid;Acute","RS2032582_ABCB1_43|rs2032582|ABCB1|Efficacy|3|cytarabine;daunorubicin;dexrazoxane;idarubicin|Leukemia;Myeloid;Acute","RS2070673_CYP2E1_1|rs2070673|CYP2E1|Toxicity|3|cytarabine;fludarabine;gemtuzumab ozogamicin;idarubicin|Leukemia;Myeloid;Acute","RS2291075_SLCO1B1_1|rs2291075|SLCO1B1|Efficacy|3|cytarabine;daunorubicin;etoposide;mitoxantrone|Leukemia;Myeloid;Acute","RS2291075_SLCO1B1_2|rs2291075|SLCO1B1|Efficacy|3|cytarabine;daunorubicin;etoposide;mitoxantrone|Leukemia;Myeloid;Acute","RS2302948_SULT2B1_1|rs2302948|SULT2B1|Toxicity|3|cytarabine;fludarabine;gemtuzumab ozogamicin;idarubicin|Leukemia;Myeloid;Acute","RS2306744_DCK_1|rs2306744|DCK|Efficacy|3|cytarabine;idarubicin|Leukemia;Myeloid;Acute","RS2515641_CYP2E1_1|rs2515641|CYP2E1|Toxicity|3|cytarabine;fludarabine;gemtuzumab ozogamicin;idarubicin|Leukemia;Myeloid;Acute","RS2898950_RRM1_1|rs2898950|RRM1|Efficacy|3|cladribine;cytarabine|Leukemia;Myeloid;Acute","RS35112940_CD33_1|rs35112940|CD33|Efficacy|3|gemtuzumab ozogamicin|Leukemia;Myeloid;Acute","RS3750117_NT5C3A_1|rs3750117|NT5C3A|Efficacy|3|cytarabine;idarubicin|Leukemia;Myeloid;Acute","RS3754446_GSTM1_1|rs3754446|GSTM1|Metabolism/PK|3|busulfan|Leukemia;Myeloid;Acute","RS4149056_SLCO1B1_17|rs4149056|SLCO1B1|Toxicity|3|cytarabine;fludarabine;gemtuzumab ozogamicin;idarubicin|Leukemia;Myeloid;Acute","RS5030743_RRM2_1|rs5030743|RRM2|Efficacy|3|cladribine;cytarabine|Leukemia;Myeloid;Acute","RS5065_NPPA_1|rs5065|NPPA|Efficacy|3|amlodipine;chlorthalidone|Cardiovascular Disease;Coronary Disease;Stroke","RS532545_CDA_1|rs532545|CDA|Efficacy|3|cytarabine|Leukemia;Myeloid;Acute;Neoplasms","RS669_A2M_1|rs669|A2M|Efficacy|3|Enzymes|Stroke","RS80143932_DCK_1|rs80143932|DCK|Efficacy|3|cytarabine;idarubicin|Leukemia;Myeloid;Acute","RS8192950_CES1_1|rs8192950|CES1|Efficacy|3|clopidogrel|Cerebrovascular Disorders;Stroke;Transient Ischemic Attack","RS8330_UGT1A_UGT1A9_1|rs8330|UGT1A,UGT1A9|Toxicity|3|acetaminophen|Liver Failure;Acute"]}]}